Home
NSE: ASTALLTD
PE
Historical P/E Ratio of Astal Laboratories Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
NSE: ASTALLTD
Share Price
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
14 Jan 2025 | 73.56 | 75.88 | 76.96 | 73.56 |
13 Jan 2025 | 77.43 | 81.5 | 81.5 | 77.43 |
10 Jan 2025 | 81.5 | 78.85 | 82.89 | 78.85 |
09 Jan 2025 | 81.46 | 85 | 85 | 81 |
08 Jan 2025 | 82.99 | 86.64 | 86.64 | 79.75 |
07 Jan 2025 | 83.9 | 85.5 | 86.3 | 82.06 |
06 Jan 2025 | 83.82 | 87.9 | 87.9 | 80.45 |
03 Jan 2025 | 84.17 | 86.49 | 86.5 | 82.23 |
02 Jan 2025 | 82.58 | 77.1 | 82.58 | 77.1 |
01 Jan 2025 | 78.65 | 81 | 83 | 77 |
Date | Price (₹) |
---|---|
14 Jan 2025 | 73.56 |
13 Jan 2025 | 77.43 |
10 Jan 2025 | 81.5 |
09 Jan 2025 | 81.46 |
08 Jan 2025 | 82.99 |
07 Jan 2025 | 83.9 |
06 Jan 2025 | 83.82 |
03 Jan 2025 | 84.17 |
02 Jan 2025 | 82.58 |
01 Jan 2025 | 78.65 |
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Company | Market Cap | PE Ratio |
---|
Astal Laboratories Ltd | 129.76 | 27.35 |
Sun Pharmaceuticals Industries Ltd | 424382 | 37.9 |
Divis Laboratories Ltd | 159224 | 86.7 |
Cipla Ltd | 116943 | 25.3 |
Dr Reddys Laboratories Ltd | 111588 | 20.9 |
Company | Market Cap |
---|---|
Astal Laboratories Ltd | 129.76 |
Sun Pharmaceuticals Industries Ltd | 424382 |
Divis Laboratories Ltd | 159224 |
Cipla Ltd | 116943 |
Dr Reddys Laboratories Ltd | 111588 |
₹129.76
Market cap
₹4
Earnings
27.4X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E ratio = (CMP of share/ Earning per share)
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical Market Cap of Astal Laboratories Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Revenue, EBITDA and Net Profit of Astal Laboratories Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Astal Laboratories Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Astal Laboratories will hold a meeting of the Board of Directors of the Company on 12 November 2024
Read more
2024-11-07 00:00:00
Net profit of Astal Laboratories rose 257.14% to Rs 2.00 crore in the quarter ended September 2024 a
Read more
2024-11-13 00:00:00
Astal Laboratories will hold a meeting of the Board of Directors of the Company on 27 November 2024
Read more
2024-11-23 00:00:00